Determination of the effectiveness of Pseudorabies marker vaccines in experiments and field trials.
The aim of vaccination in an eradication campaign is not only to induce clinical protection, but primarily to stop transmission of infections within and between herds by inducing herd immunity. Consequently, vaccines should be evaluated for their capacity to reduce virus transmission in the population. Glycoprotein E (gE) negative marker vaccines against Pseudorabies virus (PRV) infections in pigs have been evaluated this way in experiments and field studies. PRV infection in groups of (vaccinated) pigs was determined by measuring antibodies against gE of PRV from regularly taken serum samples. For the statistical analysis of the experiments a stochastic susceptible-infectious-removed (SIR) model was used. A measure for the transmission of virus is the reproduction ratio R, which is defined as the average number of secondary cases caused by one typical infectious individual. This implies that an infection will always fade out in a population when R < 1, but the infection can spread massively when R > 1. From several experiments it was shown that R < 1. Field studies showed that the R within herds was still > 1, but by reducing further contacts the R could be reduced to a value below one. This would imply that PRV could be eradicated by means of vaccination. In The Netherlands, an eradication campaign was launched in 1993, and in 2002 the virus was eradicated, as shown by a negligible number of gE-positive pigs. Farmers' organizations have to decide whether or not to stop vaccination.
Bouma
Annemarie
A
Department of Farm Animal Health, Faculty of Veterinary Medicine, Utrecht University, Yalelaan 7, 3584 CL Utrecht, The Netherlands. a.bouma@vet.uu.nl
D000818:Animals; D005069:Evaluation Studies as Topic; D009426:Netherlands / Q000453:epidemiology; D015995:Prevalence; D011557:Pseudorabies / Q000453:epidemiology / Q000517:prevention & control* / Q000635:transmission; D022421:Pseudorabies Vaccines / Q000592:standards / Q000627:therapeutic use; D013552:Swine; D013553:Swine Diseases / Q000453:epidemiology / Q000517:prevention & control* / Q000635:transmission; D014611:Vaccination / Q000662:veterinary; D022581:Vaccines, Marker
D022421:Pseudorabies Vaccines; D022581:Vaccines, Marker